DERMATX LTD

What DERMATX LTD does

DermaTx Ltd is a UK-based, privately-held skincare company founded in 2014 and headquartered in Leicester. It develops, manufactures, and sells targeted cosmeceutical skincare products under three ranges — Clarify (acne, oily skin, enlarged pores), Brighten (uneven skin tone, sun damage, ageing), and Rejuvenate (normal to sensitive skin) — plus a Solar SPF50+ DNA Repair sunscreen. The product line comprises 10 SKUs spanning cleansers, serums, moisturisers, and SPF, formulated with clinical-strength active ingredients (salicylic acid, lactic acid, glycolic acid, tranexamic acid, niacinamide, peptides, vitamins C and E, hyaluronic acid, ferulic acid, and antioxidants) combined with microdermabrasion techniques.

The company's underlying technology centres on high-concentration cosmeceutical actives paired with a multi-modal physical/chemical/mechanical exfoliation approach. Products are positioned as dermatologically tested, paraben-free, SLS-free, alcohol-free, fragrance-free, and not tested on animals, and are manufactured under UK and EU cosmetic regulations.

DermaTx operates a direct-to-consumer e-commerce business model through its owned website (dermatx.co.uk), selling to individual consumers on a one-time purchase basis (no subscription). Prices range from £21 to £36 per unit. Distribution is UK-domestic via Royal Mail Tracked with same-day dispatch, plus tiered international shipping to 40+ countries across Europe, North America, Asia-Pacific, the Middle East, and rest-of-world zones. Customer acquisition relies on influencer and blogger partnerships, email newsletter lead capture (10% first-order discount), and organic social presence on Facebook and Twitter. The company is bootstrapped, with 1–10 employees and no disclosed funding rounds or institutional investors.

Name

DERMATX LTD

Legal name

DermaTx

Website

https://dermatx.co.uk

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

DermaTx is a UK-based, bootstrapped skincare company that develops and sells targeted cosmeceutical products across three ranges (Clarify, Brighten, Rejuvenate) plus SPF via direct-to-consumer e-commerce to UK and international consumers.

Ownership category

akta.pro rank

Product category

Clinical Skincare / Cosmeceuticals

NAICS

Cosmetics, Beauty Supplies, and Perfume Retailers (456120)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Sensitive Skin & Barrier Repair (CRABAAAG), Antibacterial & Medicated Cleansers (e.g., Acne, Antifungal, Antiseptic) (CRABAEAH)

Keywords

• Clinical strength skincare
• Cosmeceutical formulations
• Acne treatment products
• Anti ageing skincare
• Direct to consumer beauty

Headquarters

HQ city

Leicester

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D

Revenue model

1. Direct Product Sales: Revenue is generated through one-time purchase transactions of skincare products sold directly to consumers via the e-commerce website. No subscription or recurring revenue model is apparent.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

DermaTx develops and sells a portfolio of targeted clinical-strength cosmeceutical skincare products organised into three ranges — Clarify (for acne, oily skin and enlarged pores), Brighten (for uneven skin tone, sun damage and ageing) and Rejuvenate (for normal to sensitive skin) — including cleansers, serums, moisturisers and an SPF50+ DNA Repair sunscreen. Products are formulated with active ingredients such as salicylic acid, lactic acid, glycolic acid, niacinamide, hyaluronic acid, vitamins C and E, ferulic acid, tranexamic acid and peptides, and are sold as one-time purchases directly to consumers via the company's e-commerce website with worldwide shipping.

Product overview

DermaTx Advanced Skincare is a UK-based skincare brand offering three targeted product ranges: Clarify (for acne, oily skin, and enlarged pores), Brighten (for uneven skin tone, sun-damaged, and ageing skin), and Rejuvenate (for normal to sensitive skin). The portfolio includes cleansers, serums, moisturisers, and SPF50+ sunscreen, all formulated with clinically proven active ingredients at optimal clinical strength. Products include the Clarify Salicylic Cleanser, Clarify Clear Skin Cream, Clarify Clear Skin Serum, Brighten Glycolic Cleanser, Brighten Pigment Corrector, Brighten Age Corrective Moisturiser, Rejuvenate Lactic Cleanser, Rejuvenate AOX Serum, Rejuvenate Revitalising Cream, and Solar SPF50+ DNA Repair. The Clarify Salicylic Cleanser won the OK! Magazine Beauty Award for Best New Facial Cleansing Product in 2018.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Products deliver visible results in minutes with no downtime
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Cetaphil: Galderma-owned sensitive-skin and acne cleanser brand; directly comparable to DermaTx's Rejuvenate (sensitive) and Clarify (acne/salicylic cleanser) ranges at mass-market scale.
• CeraVe: Dermatologist-developed skincare brand owned by L'Oréal with broad salicylic, glycolic, and ceramide-based ranges — overlaps DermaTx's clinical-strength positioning at much larger scale.
• Dermalogica: Professional-grade skincare brand spanning acne, ageing and sensitive skin — overlaps DermaTx's three-range structure with a stronger professional/spa channel presence.
• SkinCeuticals: L'Oréal-owned clinical skincare brand with vitamin C, AHA, and corrective serums positioned at premium clinical strength — comparable on active-ingredient emphasis, though at a higher price tier.
• La Roche-Posay: L'Oréal-owned dermocosmetics brand with salicylic acne and anti-ageing ranges plus SPF50+ offerings; competes in the same sensitive/acne/ageing skincare niches DermaTx addresses.

Direct peers

• Paula's Choice: Clinical, research-driven skincare brand with BHA/AHA-led acne and anti-ageing lines; directly comparable on formulation philosophy (salicylic, glycolic, niacinamide) and target consumer.
• The Inkey List: Affordable actives-led skincare brand targeting the same ingredient-literate consumer as DermaTx; comparable on price, single-active emphasis, and D2C-plus-retail distribution model.
• The Ordinary (DECIEM): Direct-to-consumer clinical-strength skincare brand built on affordable single-active formulations (AHA/BHA, vitamin C, peptides). Closest comparable to DermaTx on positioning, ingredient philosophy, and price architecture.

Regional players

• Eve Lom: UK-based prestige skincare brand with cleansers and treatment products — comparable as a UK-headquartered D2C-plus-retail skincare brand targeting similar ingredient-conscious consumers.
• Alpha-H: Australia-based clinical skincare brand built around glycolic acid and active-led regimens — comparable positioning on clinical-strength resurfacing/anti-ageing, similar size and channel mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/dermatx
• Facebookfacebook.com/dermatx
• LinkedInlinkedin.com/company/dermatx-ltd

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DERMATX LTD